share_log

8-K: Current report

8-K: Current report

8-K:重大事件
美股SEC公告 ·  09/06 09:29
Moomoo AI 已提取核心訊息
On September 6, 2024, Safety Shot, Inc., a Delaware-based wellness company, announced the Notice of Allowance for a new U.S. patent for its clinically-backed formula designed to rapidly reduce blood alcohol content (BAC). The patent is a significant addition to the company's portfolio, distinguishing Safety Shot as a leader in a new market category aimed at addressing alcohol-related issues. COO David Sandler and CEO Jarret Boon, co-owners of the patent, emphasized the patent's role in reinforcing the company's competitive edge and its commitment to consumer solutions. Safety Shot's product, which supports alcohol metabolism and reduces toxin buildup, is available online and is expanding into business-to-business sales. The announcement also included forward-looking statements regarding the company's plans and potential risks as disclosed in its SEC filings.
On September 6, 2024, Safety Shot, Inc., a Delaware-based wellness company, announced the Notice of Allowance for a new U.S. patent for its clinically-backed formula designed to rapidly reduce blood alcohol content (BAC). The patent is a significant addition to the company's portfolio, distinguishing Safety Shot as a leader in a new market category aimed at addressing alcohol-related issues. COO David Sandler and CEO Jarret Boon, co-owners of the patent, emphasized the patent's role in reinforcing the company's competitive edge and its commitment to consumer solutions. Safety Shot's product, which supports alcohol metabolism and reduces toxin buildup, is available online and is expanding into business-to-business sales. The announcement also included forward-looking statements regarding the company's plans and potential risks as disclosed in its SEC filings.
2024年9月6日,康健音科有限公司(Safety Shot, Inc.)宣佈獲得美國一項新專利的許可通知。該專利是該公司投資組合的一項重要補充,使Safety Shot成爲新的市場領導者,旨在解決與酒精相關的問題。首席運營官大衛·桑德勒(David Sandler)和首席執行官賈瑞特·布恩(Jarret Boon)作爲該專利的共同所有人,強調了該專利在鞏固公司競爭優勢和承諾爲消費者提供解決方案方面的作用。Safety Shot的產品可以支持酒精代謝,減少毒素積累,可在線購買,並且正在擴展到企業間業務銷售。該公告還包括關於公司計劃和潛在風險的前瞻性聲明,這些聲明已在其美國證券交易委員會(SEC)的文件中披露。
2024年9月6日,康健音科有限公司(Safety Shot, Inc.)宣佈獲得美國一項新專利的許可通知。該專利是該公司投資組合的一項重要補充,使Safety Shot成爲新的市場領導者,旨在解決與酒精相關的問題。首席運營官大衛·桑德勒(David Sandler)和首席執行官賈瑞特·布恩(Jarret Boon)作爲該專利的共同所有人,強調了該專利在鞏固公司競爭優勢和承諾爲消費者提供解決方案方面的作用。Safety Shot的產品可以支持酒精代謝,減少毒素積累,可在線購買,並且正在擴展到企業間業務銷售。該公告還包括關於公司計劃和潛在風險的前瞻性聲明,這些聲明已在其美國證券交易委員會(SEC)的文件中披露。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息